待处理
入排:排除
图源:待检查
Comment on: ALBAN (GETUG-AFU 37): a phase III, randomized, open-label, international trial of intravenous atezolizumab and intravesical Bacillus Calmette-Guérin (BCG) versus BCG alone in BCG-naive high-risk, non-muscle-invasive bladder cancer (NMIBC).
R Contieri, V Mollica, S F Shariat, B Pradere
Ann Oncol 37(5) 747-749
摘要
摘要
无摘要
KM 提取结果
0 个 Figure · 0 个 KM 面板